Special Presentation: What if You Could Predict the Risk of Radiation Effects – Prostox and Beyond
Featuring Dr. Joanne Weidhaas, developer of the Prostox test. Dr. Weidhaas is a radiation oncologist/ professor at UCLA. Co-discoverer of the biomarker KRAS-variant, she co-founded MiraDx, maker of Prostox, and MiraKind to empower individuals with meaningful health information. Dr. Weidhass’ professional and academic resume includes MSKCC, Yale and Stanford, largely in breast cancer. She also finds time to care for 3 kids and save dogs!
Check out our Veterans and mental health too, including art and creative writing classes. All AnCan sessions are free and all except the Art Class are drop-in – no pre-registration.
Take a look at the recording of our latest webinar presentation featuring guest speaker Dr. Jonathan Epstein, MD, a leader in Advanced Uropathology. Thanks to guest panelists Dr. John Antonucci, MD, Dr. Randall Jones, PhD, and Howard Wolinsky.
Reliable biopsies are critical to selecting the right treatment at all stages of prostate cancer – we’re talking needle tissue, not blood, btw. Get it wrong and you may get too much or too little treatment.
Reading pathology is part art and part science! AnCan Advisory Board Member, Dr. Jonathan Epstein is globally acknowledged to have the best eye in the genitourinary pathology world. AnCan frequently refers men to him for a 2nd opinion. His presentation will include:
Getting the most out of a 2nd Opinion
The relevance of cribriform, intraductal, ductal, & small cells
AnCan thanks the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, Blue Earth Diagnostics, and Foundation Medicine. Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators, and Participants.
AnCan does not accept sponsored promotions. Any drugs, protocols, or devices discussed are based solely on anecdotal peer experience or clinical evidence. AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so, call 1-800-332-1066 or download the interactive FDA Form 3500 https://www.fda.gov/media/76299/download
To SIGN UP for any of our Virtual Support groups, visit our Contact Us page
In our prostate cancer world, getting 2nd opinions is critical. It’s easy to find a medical second opinion, and you can have your pathology reread by the best. But MRIs – that’s been challenging.
Now there’s an affordable AI-validated option that’s proven very reliable* – ProstatID
Founder and Developer, Randall Jones, PhD, explains the technology and its uses. Hosted by AnCan Advisory Board Member and prostate cancer peer, Cdr. Mike Crosby
AnCan thanks the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, Blue Earth Diagnostics, and Foundation Medicine. Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators, and Participants.
AnCan does not accept sponsored promotions. Any drugs, protocols, or devices discussed are based solely on anecdotal peer experience or clinical evidence. AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so, call 1-800-332-1066 or downloadthe interactive FDA Form 3500 https://www.fda.gov/media/76299/download
To SIGN UP for any of our Virtual Support groups, visit our Contact Us page.
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.
WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!
Editor’s Pick: Leverage second opinions when in decision making mode (bj)
Topics Discussed
Following PSA levels after prostatectomy — how low, how fast, how often; understanding undetectable PSA following surgery; newly diagnosed seeks second opinion; active surveillance; getting the most out of in-person medical conferences; focal vs definitive treatment; germline (inherited mutation) testing and the Promise Study; Post radiation urinary issues — irritation and flow; managing symptoms of long covid during radiation treatment; importance of getting a second opinion from a prostate cancer center of excellence; attending PCRI conference — visit AnCan
Chat Log
Boykin Jordan (DC Metro)
A lot of fun!
Jerry Grimes, Brighton, MI
Oops, I had the wrong meeting! All the best, and I’ll show myself out… ?
AnCan – rick
Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822716
AnCan Barniskis Room
This Weds 7:30 pm PT Kelly Spillman a comedian who does a stand-up comedy routine about living with cancer will perform online at ANCAN Solo Arts Heal. Please share this if you know someone dealing with cancer. Kelly Spillman is a psychology professor, stand-up comedian and storyteller based in Los Angeles. Kelly has performed at The Comedy Store, The Improv and many comedy festivals around the country. She is currently touring her solo show I Blame Florida which is a humorous, hopeful show about her quest to beat her stage 4 colon cancer diagnosis. To Watch: Click On :https://themarsh.org/soloartsheal/ Scroll down to mid-page where you can click to view in Zoom or YouTube
AnCan – rick
Promise study https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar
AnCan – rick
Darryl – here’s our phone number to dial in 646 749 3129 #222 583 973
Jim Stewart Reno, NV
have to sign off to get grandkids, goodnight everyone
AnCan – rick
Is he new??
AnCan – rick
rickd13.sg-host.com
AnCan – rick
NCI Centers http://www.cancer.gov/research/nci-role/cancer-centers/find
AnCan – rick
NCCN http://www.nccn.org/members/network.aspx
Are you ready to get the inside scoop on clinical trials? Get ready to delve deep with former clinical trial nurse coordinator Marni Tierno. We know it can be a complex and overwhelming topic, but don’t worry – we’re here to break it down in a way that’s easy to understand.
Also featuring the vast professional experience of Wendy Garvin Mayo, we’ll tackle the myths and misconceptions that often surround clinical trials, giving you the facts and insights you need to make informed decisions.
Whether you’re a patient, carepartner, or simply curious about clinical trials, this webinar is for you! Our aim is to empower you with a deep understanding, allowing you to make the best choices for yourself or your loved ones.
Some of the topics we will cover include:
Description of the types and phases of clinical trials
Examples of pivotal clinical trials that have changed how we treat cancer
What to expect when participating in a clinical trial (including potential risks and benefits)
Addressing common questions about clinical trial participation
and more!
Watch here: (closed captioning is provided for this webinar, click the CC button at the bottom next to the gear.)
To view the slides from this webinar, please click here.
Special thanks to Bayer, Novartis, Johnson & Johnson, Foundation Medicine, Myriad Genetics, Telix, and Blue Earth Diagnostics for sponsoring this webinar.
And very special thanks to Illumina and Collaborative Cancer Care for letting us have two of their absolute best people present for us!
.
To SIGN UP for any of our Virtual Support groups, visit our Contact Us page.
Highlights of the top prostate cancer papers from the recent ASCO annual conference were presented by AnCan moderators in a special 75-minute session preceding the 7/1/2024 High Risk / Recurrent / Advanced prostate cancer meeting. Moderators Rick Davis, John Antonucci, Len Sierra, and Ben Nathanson spoke, followed by a 30-minute audience Q&A.
Topics we covered:
* Sequence your tumor before Pluvicto
* More tough news if you’ve got the bad mutations…
* With a BRCA mutatoin, get that PARP-I quickly!
* Readily available solution to hot flashes if you’re on abi
* State-of-the-art personalized medicine and imaging
* Cushioning the blows of ADT
* A flop for metformin
* Who should get treatment holidays?
* Is alpha radiation the top dog?
* Pressing AR’s self-destruct
* An angle on neuroendocrine
* Predicting winners at immunotherapy
* Who’ll connect at BAT?
* Doublet faceoff: ADT+ chemo vs ADT+ARPI
* In triplet trials, who really needed chemo?
* Ranking PARP inhibitors for bone-marrow complications
. 
